Table 1.

Patients with drug-resistant epilepsy

IDAge/sexTypeSZ typeElc.SurgeryOutcome
Group 1
 118/MLesional, temporalCPS+GTCSLeft anterior TL, AMG, and partial HIPPSeizure recurrence
 217/FLesional, extratemporalCPS+GTCSRight inferior OLSeizure free
 314/naLesional, extratemporalCPS+GTCSLeft posterior PLSeizure free
Group 2
 449/FLesional, temporalCPSSLeft selective AMG and HIPPSeizure free
 55/MNonlesional, extratemporalPSSRight posterior TL and OLSeizure free
 624/MLesional, extratemporalCPSSRight anterior TL, AMG, and HIPP, and frontal PLSeizure free
 736/MLesional, extratemporalPSS + DRight FL, right PLSeizure free
 824/MnaPSS + DRight OL, right PLSeizure free
Group 3
 934/MNonlesional, temporalCPSSLeft TLSeizure recurrence
 1029/FLesional, extratemporalCPSSRight TL, partial OLSeizure recurrence
 1124/MNonlesional, extratemporalCPSS + DLeft FLSeizure recurrence
 1231/MNonlesional, extratemporalCPSS + DLeft FLSeizure recurrence
  • Groups 1 and 2 include patients who had a single resection. Group 3 includes patients that had previous resection surgeries. AMG, amygdalectomy; CPS, complex partial seizure; D, depth electrodes; Elc., electrode type; FL, frontal lobectomy; GTC, secondarily generalized tonic-clonic seizure; HIPP, hippocampectomy; na, information not available; OL, occipital lobectomy; PL, parietal lobectomy; PS, simple partial seizure; S, subdural grid electrodes; “Seizure free” means that no seizure was reported within six months; “Seizure recurrence” means that seizures recurred within six months postsurgery; SZ, seizure; TL, temporal lobectomy.